SCHEMBL22632115

SCHEMBL22632115

CC(=O)NCCc1cc(=O)oc2c3c4c(cc12)CCCN4CCC3

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.56
▸ KMT2A Q03164 9/20 0.56
▸ MEN1 O00255 8/20 0.56
▸ KDM4E B2RXH2 8/20 0.56
▸ USP2 O75604 6/20 0.56
▸ GAA P10253 6/20 0.56
▸ MAPT P10636 6/20 0.56
▸ LMNA P02545 5/20 0.56
▸ HSD17B10 Q99714 5/20 0.56
▸ HPGD P15428 4/20 0.56
▸ CASP1 P29466 4/20 0.56
▸ CASP7 P55210 4/20 0.56
▸ ATM Q13315 2/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ GLA P06280 2/20 0.56
▸ TDP1 Q9NUW8 3/20 0.53
▸ HTT P42858 2/20 0.53
▸ KEAP1 Q14145 1/20 0.53
▸ NFE2L2 Q16236 1/20 0.53
▸ GPR35 Q9HC97 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24623962 0.90 KMT2A (0.60) ALDH1A1KMT2AMEN1KDM4EUSP2
SCHEMBL24623242 0.89 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1KDM4EUSP2
SCHEMBL14305006 0.88 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1KDM4EUSP2
SCHEMBL14303304 0.87 KMT2A (0.60) ALDH1A1KMT2AMEN1KDM4EUSP2
SCHEMBL3205404 0.87 ALDH1A1 (0.51) ALDH1A1KMT2AMEN1KDM4EUSP2
SCHEMBL24623305 0.84 ALDH1A1 (0.64) ALDH1A1KMT2AMEN1KDM4EUSP2
SCHEMBL22632114 0.83 KMT2A (0.55) ALDH1A1KMT2AMEN1KDM4EUSP2
SCHEMBL903151 0.82 ALDH1A1 (0.68) ALDH1A1KMT2AMEN1KDM4EUSP2
SCHEMBL3202594 0.82 KMT2A (0.61) ALDH1A1KMT2AMEN1KDM4EUSP2
SCHEMBL1212238 0.81 ALDH1A1 (0.63) ALDH1A1KMT2AMEN1KDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114072414-A Coumarin-modified androgens for the treatment of prostate cancer 健康研究股份有限公司 2022-02-18 — — CN disclosed
WO-2020223174-A1 COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER HEALTH RESEARCH, INC. (US) 2020-11-05 — — WO disclosed
Send feedback